课题基金 / 基金详情

Optimization of conversion of thebaine to oripavine and hydromorphone; 2nd-generation synthesis of hydromorphone

Optimization of conversion of thebaine to oripavine and hydromorphone; 2nd-generation synthesis of hydromorphone
蒂巴因向东罂粟碱和氢吗啡酮转化的优化;
批准号:
470630-2014
负责人:
Hudlicky, Tomas
金额:
$8.81万
依托单位:
依托单位国家:
加拿大
项目类别:
Idea to Innovation
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-01-01 至 2015-12-31

项目摘要

项目成果

Hudlicky, Tomas的其他基金

相似基金

相关文献

中文摘要
翻译
拟议的项目涉及将茶碱转化为东方滨,并将东方碱转化为氢吗啡酮,氢吗啡酮是一种用于止痛的重要止痛剂。加拿大对氢吗啡的年需求量稳步增加到每年约1600公斤,全球产量估计为6.1吨,全球(合法)消费量为3.4吨。
英文摘要
The proposed project is concerned with the conversion of thebaine to oripavine, and oripavine to hydromorphone, an important analgesic agent used for pain control. The annual demand for hydromorphone in Canada has steadily increased to about 1,600 kg/year, with global production estimated at 6.1 tons and global (legal) consumption at 3.4 tons.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Organic Synthesis and Biocatalysis
  • 批准号:
    CRC-2016-00268
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $7.6万
  • 财政年份:
    2022
  • 负责人:
    Hudlicky, Tomas
  • 依托单位:
Program in the chemoenzymatic synthesis of alkaloids and medicinal agents and the development of new chiral building blocks, asymmetric protocols, and reagents
  • 批准号:
    RGPIN-2018-03723
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $5.76万
  • 财政年份:
    2022
  • 负责人:
    Hudlicky, Tomas
  • 依托单位:
Program in the chemoenzymatic synthesis of alkaloids and medicinal agents and the development of new chiral building blocks, asymmetric protocols, and reagents
  • 批准号:
    RGPIN-2018-03723
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $5.76万
  • 财政年份:
    2021
  • 负责人:
    Hudlicky, Tomas
  • 依托单位:
Organic Synthesis And Biocatalysis
  • 批准号:
    CRC-2016-00268
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $14.57万
  • 财政年份:
    2021
  • 负责人:
    Hudlicky, Tomas
  • 依托单位:
国内基金
海外基金
二氧化碳与高碳烷烃耦合转化多相催化体系研究
有机氟化合物功能基团的化学转换及其应用研究